On the afternoon of March 9th, 2024, the first executive council of the sixth session of the Nanjing Natural Medicine Association was successfully held at the Drum Tower in Nanjing.
The President of the Council, Zhou Chunxiang, reported and summarized the work of the Natural Medicine Association in 2023 at the meeting, and released the work plan and arrangement for 2024.
More than 20 members of the society's specialized committee attended this meeting. As an executive director unit of the Nanjing Natural Medicine Association, Nanjing Daoqun Health Management Company also participated in this meeting and made a report on the work of the association for 23 years.
In the past year, Nanjing Daoqun Health Management Co., Ltd. was committed to combining chronic disease management with the Internet and "moving" chronic disease management services online. Daoqun Health uses emerging forms of Internet content communication, such as short videos, live lectures, etc., to invite well-known experts to share health care knowledge such as chronic disease management and traditional Chinese medicine health care.
In 2024, Daoqun R&D company will also launch more drugs suitable for chronic disease patients, such as 100mg aspirin enteric coated tablets. 100mg aspirin is a recommended antithrombotic drug by authoritative guidelines both domestically and internationally. It is safer and more suitable for middle-aged and elderly people when taken as an enteric solvent.
In the new year, Nanjing Daoqun Health Management Company will continue to provide more diversified chronic disease management services and bring more medical products suitable for chronic disease patients, using various forms to help patients do a good job in chronic disease management. Together with Nanjing Medical Association, we will promote the development of natural medicine in China.
